Chapter

Secondary dyslipidaemias

Rafael Carmena and José T. Real

in Hyperlipidaemia

Published on behalf of Oxford University Press

ISBN: 9780199543502
Published online October 2011 | e-ISBN: 9780199607204 | DOI: http://dx.doi.org/10.1093/med/9780199543502.003.0005

Series: Oxford Cardiology Library

Secondary dyslipidaemias

Show Summary Details

Preview

• Secondary causes including concurrent drug therapy should be sought and excluded in patients presenting with dyslipidaemia. • Depending on the cause, treatment is of the underlying condition, for example, hypothyroidism. • Lipid lowering is required in addition to treatment of the underlying cause in some conditions such as diabetes, kidney disease, and HIV/AIDS. • Dyslipidaemia is commonly seen in type 2 diabetes and metabolic syndrome, and its treatment is an important component of overall management.

Chapter.  4098 words. 

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.